DNMT3A and acute promyelocytic leukemia: Di Croce found that PML-RAR fusion protein, an oncogenic transcription factor, recruited DNMT1 and DNMT3A to retinoic acid receptor beta 2 leading to its methylation and subsequent gene silencing in acute promyelocytic leukemia (APL) [91].